- Development of Medical Countermeasures for Biodefense and Emerging Infectious Diseases, Base, Option 1 and Option 2 Award, 09/16/2013 - 09/15/2017
Contract Overview
Contract Amount: $47,755,723 ($47.8M)
Contractor: Biocryst Pharmaceuticals Inc
Awarding Agency: Department of Health and Human Services
Start Date: 2013-09-16
End Date: 2022-09-30
Contract Duration: 3,301 days
Daily Burn Rate: $14.5K/day
Official Description: IGF::OT::IGF - DEVELOPMENT OF MEDICAL COUNTERMEASURES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES, BASE, OPTION 1 AND OPTION 2 AWARD, 09/16/2013 - 09/15/2017
Place of Performance
Location: North Carolina, 27703